Expert Interview
Discussing the potential impact of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, on the treatment of mixed dyslipidemia and its implications for future cardiovascular disease management
Ticker(s): LLYInstitution: Private Practice
- Board-certified clinical lipidologist in private practice located in Scottsdale, Arizona.
- Currently manages 20 patients with elevated levels of lipoprotein(a).
- Currently serves as a Principal Investigator on 12 clinical trials.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
